Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.

Quotes for Respiratorius AB

Right Now

+/-
0.001
%
1,39%
Latest
0.0728
High
0.0728
Low
0.07
Volume
1 291 327
Turnover (SEK)
91 639
Market Value (MSEK)
21,3
Time (Latest trade)
2024-06-14 14:39

Board

CEO

  • Johan Drott

Chairperson of the Board

  • Karin Wehlin

Board

  • Johan Drott
  • Kristina Drott
  • Mia Lundblad

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 8,28 8,28 2024-03-26
Valcuria Holding AB 3,86 3,86 2024-03-26
Ben Hayes 2,32 2,32 2024-03-26
Hans Harvig 1,72 1,72 2024-03-26
Hans Mandahl 1,20 1,20 2024-03-26
Benny Bengtsson 1,09 1,09 2024-03-26
Göran Lennart Rehn 0,99 0,99 2024-03-26
Hartmut Wiese 0,99 0,99 2024-03-26
Christian Müller 0,99 0,99 2024-03-26
Nordnet Pensionsförsäkring 0,90 0,90 2024-03-26
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream